These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 27113046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 3. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K, Rommel KP, Lapusca R, Blazek S, Besler C, Hartung P, von Roeder M, Kresoja KP, Desch S, Thiele H, Lurz P.
    Hypertension; 2019 Aug 10; 74(2):341-348. PubMed ID: 31203726
    [Abstract] [Full Text] [Related]

  • 4. Safety and Clinical Outcome of the Delivery of Radiofrequency Nerve Ablation Therapy in a Renal Artery of Unusual Anatomy.
    de Leon-Martinez EP, Garza JA, Azpiri-Lopez JR, Dillon KN, Salazar LO, Canepa-Campos F, Rousselle SD, Tellez A.
    High Blood Press Cardiovasc Prev; 2015 Dec 10; 22(4):445-8. PubMed ID: 26014838
    [Abstract] [Full Text] [Related]

  • 5. Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation.
    VonAchen P, Hamann J, Houghland T, Lesser JR, Wang Y, Caye D, Rosenthal K, Garberich RF, Daniels M, Schwartz RS.
    Cardiovasc Revasc Med; 2016 Dec 10; 17(7):470-473. PubMed ID: 27493150
    [Abstract] [Full Text] [Related]

  • 6. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
    Fengler K, Rommel KP, Blazek S, Besler C, Hartung P, von Roeder M, Petzold M, Winkler S, Höllriegel R, Desch S, Thiele H, Lurz P.
    Circulation; 2019 Jan 29; 139(5):590-600. PubMed ID: 30586691
    [Abstract] [Full Text] [Related]

  • 7. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
    Lauder L, Ewen S, Tzafriri AR, Edelman ER, Cremers B, Kulenthiran S, Ukena C, Linz D, Kindermann I, Tsioufis C, Scheller B, Böhm M, Mahfoud F.
    Cardiovasc Revasc Med; 2018 Jan 29; 19(7 Pt B):845-851. PubMed ID: 29555535
    [Abstract] [Full Text] [Related]

  • 8. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.
    Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M.
    Lancet; 2009 Apr 11; 373(9671):1275-81. PubMed ID: 19332353
    [Abstract] [Full Text] [Related]

  • 9. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 11; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 10. Does the presence of accessory renal arteries affect the efficacy of renal denervation?
    Id D, Kaltenbach B, Bertog SC, Hornung M, Hofmann I, Vaskelyte L, Sievert H.
    JACC Cardiovasc Interv; 2013 Oct 11; 6(10):1085-91. PubMed ID: 24156968
    [Abstract] [Full Text] [Related]

  • 11. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S, Okon T, Heinemann D, Kulle K, Röhnert K, Sonnabend M, Petzold M, Müller U, Schuler G, Eitel I, Thiele H, Lurz P.
    Hypertension; 2015 Jun 11; 65(6):1202-8. PubMed ID: 25824248
    [Abstract] [Full Text] [Related]

  • 12. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Duval J, Lee R, Sata Y, Krum H, Lambert E, Peter K, Head G, Lambert G, Esler MD, Schlaich MP.
    Int J Cardiol; 2016 Jan 01; 202():388-93. PubMed ID: 26432488
    [Abstract] [Full Text] [Related]

  • 13. Renal Nerve Stimulation-Induced Blood Pressure Changes Predict Ambulatory Blood Pressure Response After Renal Denervation.
    de Jong MR, Adiyaman A, Gal P, Smit JJ, Delnoy PP, Heeg JE, van Hasselt BA, Lau EO, Persu A, Staessen JA, Ramdat Misier AR, Steinberg JS, Elvan A.
    Hypertension; 2016 Sep 01; 68(3):707-14. PubMed ID: 27432864
    [Abstract] [Full Text] [Related]

  • 14. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG, Wilkins GT, Webster MW, Montarello JK, Delacroix S, Whitbourn RJ, Warren RJ.
    Atherosclerosis; 2017 Jul 01; 262():94-100. PubMed ID: 28531827
    [Abstract] [Full Text] [Related]

  • 15. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience.
    Fischell TA, Ebner A, Gallo S, Ikeno F, Minarsch L, Vega F, Haratani N, Ghazarossian VE.
    JACC Cardiovasc Interv; 2016 Mar 28; 9(6):589-98. PubMed ID: 27013159
    [Abstract] [Full Text] [Related]

  • 16. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P, Cremer A, Pereira H, Bobrie G, Chatellier G, Chamontin B, Courand PY, Delsart P, Denolle T, Dourmap C, Ferrari E, Girerd X, Michel Halimi J, Herpin D, Lantelme P, Monge M, Mounier-Vehier C, Mourad JJ, Ormezzano O, Ribstein J, Rossignol P, Sapoval M, Vaïsse B, Zannad F, Azizi M.
    Hypertension; 2017 Mar 28; 69(3):494-500. PubMed ID: 28115517
    [Abstract] [Full Text] [Related]

  • 17. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG.
    Hypertension; 2014 Sep 28; 64(3):565-72. PubMed ID: 24935940
    [Abstract] [Full Text] [Related]

  • 18. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M, SPYRAL HTN-OFF MED trial investigators*.
    Lancet; 2017 Nov 11; 390(10108):2160-2170. PubMed ID: 28859944
    [Abstract] [Full Text] [Related]

  • 19. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
    Kiuchi MG, Chen S, Rodrigues Paz LM, Pürerfellner H.
    Hipertens Riesgo Vasc; 2018 Nov 11; 35(2):54-63. PubMed ID: 28784273
    [Abstract] [Full Text] [Related]

  • 20. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
    Danilov NM, Matchin IuG, Chazova IE.
    Angiol Sosud Khir; 2012 Nov 11; 18(1):51-4. PubMed ID: 22836328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.